Potential biomarkers for oral squamous cell carcinoma: Proteomics discovery and clinical validation

Proteomics - Clinical Applications

Volumn 9, Issue 1-2, 2015, Pages 86-97

  Ni, Yan hong ^a   Ding, Liang ^a   Hu, Qin gang ^a   Hua, Zi Chun ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Oral squamous cell carcinoma (OSCC); Tumor biomarkers

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; CATALASE; COFILIN; FIBRINOGEN; FICOLIN; HAPTOGLOBIN; HEAT SHOCK PROTEIN; KERATIN; MESSENGER RNA; PROFILIN; PROTEIN 14 3 3; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SUPEROXIDE DISMUTASE; TRANSFERRIN; TUBULIN; PROTEOME; TUMOR MARKER; TUMOR PROTEIN;

BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; EARLY DIAGNOSIS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INVASIVE CARCINOMA; LEUKOPLAKIA; LYMPH NODE METASTASIS; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SALIVA ANALYSIS; SURVIVAL RATE; TISSUE FIXATION; TUMOR RECURRENCE; CARCINOMA, SQUAMOUS CELL; METABOLISM; MOUTH NEOPLASMS; PROCEDURES;

CARCINOMA, SQUAMOUS CELL; HUMANS; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84922922549     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400091     Document Type: Review

References (69)

1. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P., Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55, 74-108.
2. Carvalho, A. L., Nishimoto, I. N., Califano, J. A., Kowalski, L. P., Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int. J. Cancer 2005, 114, 806-816.
3. Gillison, M. L., Koch, W. M., Capone, R. B., Spafford, M. et al., Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 2000, 92, 709-720.
4. Herrero, R., Castellsague, X., Pawlita, M., Lissowska, J. et al., Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J. Natl. Cancer Inst. 2003, 95, 1772-1783.
5. Gillison, M. L., Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin. Oncol. 2004, 31, 744-754.
6. Leemans, C. R., Braakhuis, B. J., Brakenhoff, R. H., The molecular biology of head and neck cancer. Nat. Rev. Cancer 2011, 11, 9-22.
7. Argiris, A., Karamouzis, M. V., Raben, D., Ferris, R. L., Head and neck cancer. Lancet 2008, 371, 1695-1709.
8. Simental, A. A., Jr., Duvvuri, U., Johnson, J. T., Myers, E. N., Selective neck dissection in patients with upper aerodigestive tract cancer with clinically positive nodal disease. Ann. Otol. Rhinol. Laryngol 2006, 115, 846-849.
9. Lam, L., Logan, R. M., Luke, C., Rees, G. L., Retrospective study of survival and treatment pattern in a cohort of patients with oral and oropharyngeal tongue cancers from 1987 to 2004. Oral. Oncol. 2007, 43, 150-158.
10. Etzioni, R., Urban, N., Ramsey, S., McIntosh, M. et al., The case for early detection. Nat. Rev. Cancer 2003, 3, 243-252.
11. Sidransky, D., Emerging molecular markers of cancer. Nat. Rev. Cancer 2002, 2, 210-219.
12. Hayes, D. F., Bast, R. C., Desch, C. E., Fritsche, H., Jr. et al., Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J. Natl. Cancer Inst. 1996, 88, 1456-1466.
13. Kulasingam, V., Diamandis, E. P., Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat. Clin. Pract. Oncol. 2008, 5, 588-599.
14. Bast, R. C., Jr., Feeney, M., Lazarus, H., Nadler, L. M. et al., Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 1981, 68, 1331-1337.
15. Ludwig, J. A., Weinstein, J. N., Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 2005, 5, 845-856.
16. Wang, M. C., Valenzuela, L. A., Murphy, G. P., Chu, T. M., Purification of a human prostate specific antigen. Invest. Urol. 1979, 17, 159-163.
17. Garbis, S. D., Tyritzis, S. I., Roumeliotis, T., Zerefos, P. et al., Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 2008, 7, 3146-3158.
18. Domon, B., Aebersold, R., Mass spectrometry and protein analysis. Science 2006, 312, 212-217.
19. Wulfkuhle, J. D., Paweletz, C. P., Steeg, P. S., Petricoin, E. F., 3rd et al., Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv. Exp. Med. Biol. 2003, 532, 59-68.
20. Wang, Z., Feng, X., Liu, X., Jiang, L. et al., Involvement of potential pathways in malignant transformation from oral leukoplakia to oral squamous cell carcinoma revealed by proteomic analysis. BMC Genomics 2009, 10, 383.
21. Chanthammachat, P., Promwikorn, W., Pruegsanusak, K., Roytrakul, S. et al., Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand. Arch. Oral Biol. 2013, 58, 1677-1685.
22. Lo, W. Y., Tsai, M. H., Tsai, Y., Hua, C. H. et al., Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin. Chim. Acta 2007, 376, 101-107.
23. Hu, S., Yu, T., Xie, Y., Yang, Y. et al., Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 2007, 4, 55-64.
24. Patel, V., Hood, B. L., Molinolo, A. A., Lee, N. H. et al., Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin. Cancer Res. 2008, 14, 1002-1014.
25. Negishi, A., Masuda, M., Ono, M., Honda, K. et al., Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma. Cancer Sci. 2009, 100, 1605-1611.
26. Lo, W. Y., Wang, H. J., Chiu, C. W., Chen, S. F., miR-27b-regulated TCTP as a novel plasma biomarker for oral cancer: from quantitative proteomics to post-transcriptional study. J. Proteomics 2012, 77, 154-166.
27. Koehn, J., Krapfenbauer, K., Huber, S., Stein, E. et al., Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis. J. Proteome Res. 2008, 7, 3818-3829.
28. Ralhan, R., Desouza, L. V., Matta, A., Chandra Tripathi, S. et al., Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol. Cell Proteomics 2008, 7, 1162-1173.
29. Ralhan, R., Desouza, L. V., Matta, A., Chandra Tripathi, S. et al., iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. J. Proteome Res. 2009, 8, 300-309.
30. Schaaij-Visser, T. B., Graveland, A. P., Gauci, S., Braakhuis, B. J. et al., Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas. Clin. Cancer Res. 2009, 15, 7666-7675.
31. Layland, M. K., Sessions, D. G., Lenox, J., The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 2005, 115, 629-639.
32. Anneroth, G., Batsakis, J., Luna, M., Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand. J. Dent. Res. 1987, 95, 229-249.
33. Bello, I. O., Soini, Y., Salo, T., Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II). Oral Oncol. 2010, 46, 636-643.
34. Hadler-Olsen, E., Wetting, H. L., Rikardsen, O., Steigen, S. E. et al., Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts. Virchows Arch. 2010, 457, 677-692.
35. Huang, S. H., Hwang, D., Lockwood, G., Goldstein, D. P., O'Sullivan, B., Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies. Cancer 2009, 115, 1489-1497.
36. Woolgar, J. A., Triantafyllou, A., Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. Oral Oncol. 2009, 45, 361-385.
37. Naresh, K. N., Lakshminarayanan, K., Pai, S. A., Borges, A. M., Apoptosis index is a predictor of metastatic phenotype in patients with early stage squamous carcinoma of the tongue: a hypothesis to support this paradoxical association. Cancer 2001, 91, 578-584.
38. Rubio Bueno, P., Naval Gias, L., Garcia Delgado, R., Domingo Cebollada, J., Diaz Gonzalez, F. J., Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the oral cavity and tongue base. Head Neck 1998, 20, 232-239.
39. Riedel, F., Gotte, K., Bergler, W., Hormann, K., Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck. Oncol. Rep. 2001, 8, 471-476.
40. Wong, Y. K., Liu, C. J., Kwan, P. C., Chao, S. Y., Microvascular density and vascular endothelial growth factor immunoreactivity as predictors of regional lymph node metastasis from betel-associated oral squamous cell carcinoma. J. Oral. Maxillofac. Surg. 2003, 61, 1257-1262.
41. Kurtz, K. A., Hoffman, H. T., Zimmerman, M. B., Robinson, R. A., Perineural and vascular invasion in oral cavity squamous carcinoma: increased incidence on re-review of slides and by using immunohistochemical enhancement. Arch. Pathol. Lab. Med. 2005, 129, 354-359.
42. Polachini, G. M., Sobral, L. M., Mercante, A. M., Paes-Leme, A. F. et al., Proteomic approaches identify members of cofilin pathway involved in oral tumorigenesis. PLoS One 2012, 7, e50517.
43. Braakhuis, B. J., Leemans, C. R., Brakenhoff, R. H., A genetic progression model of oral cancer: current evidence and clinical implications. J. Oral Pathol. Med. 2004, 33, 317-322.
44. Califano, J., van der Riet, P., Westra, W., Nawroz, H. et al., Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996, 56, 2488-2492.
45. Vikram, B., Changing patterns of failure in advanced head and neck cancer. Arch. Otolaryngol. 1984, 110, 564-565.
46. Sutton, D. N., Brown, J. S., Rogers, S. N., Vaughan, E. D., Woolgar, J. A., The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int. J. Oral Maxillofac Surg. 2003, 32, 30-34.
47. Leemans, C. R., Tiwari, R., Nauta, J. J., van der Waal, I., Snow, G. B., Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994, 73, 187-190.
48. Braakhuis, B. J., Tabor, M. P., Leemans, C. R., van der Waal, I. et al., Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002, 24, 198-206.
49. Leemans, C. R., Tiwari, R., Nauta, J. J., van der Waal, I., Snow, G. B., Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993, 71, 452-456.
50. Fliss, M. S., Usadel, H., Caballero, O. L., Wu, L. et al., Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000, 287, 2017-2019.
51. Righini, C. A., de Fraipont, F., Timsit, J. F., Faure, C. et al., Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin. Cancer Res. 2007, 13, 1179-1185.
52. Hu, S., Arellano, M., Boontheung, P., Wang, J. et al., Salivary proteomics for oral cancer biomarker discovery. Clin. Cancer Res. 2008, 14, 6246-6252.
53. Jessie, K., Jayapalan, J. J., Ong, K. C., Abdul Rahim, Z. H. et al., Aberrant proteins in the saliva of patients with oral squamous cell carcinoma. Electrophoresis 2013, 34, 2495-2502.
54. Jou, Y. J., Lin, C. D., Lai, C. H., Chen, C. H. et al., Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal. Chim. Acta 2010, 681, 41-48.
55. Shintani, S., Hamakawa, H., Ueyama, Y., Hatori, M., Toyoshima, T., Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Int. J. Oral Maxillofac. Surg. 2010, 39, 68-74.
56. Xie, H., Onsongo, G., Popko, J., de Jong, E. P. et al., Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol. Cell. Proteomics 2008, 7, 486-498.
57. Yang, Y., Rhodus, N. L., Ondrey, F. G., Wuertz, B. R. et al., Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker. PLoS One 2014, 9, e95389.
58. de Jong, E. P., Xie, H., Onsongo, G., Stone, M. D. et al., Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS One 2010, 5, e11148.
59. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J. et al., Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
60. Li, J., Zhao, J., Yu, X., Lange, J. et al., Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin. Cancer Res. 2005, 11, 8312-8320.
61. Li, J., Zhang, Z., Rosenzweig, J., Wang, Y. Y., Chan, D. W., Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin. Chem. 2002, 48, 1296-1304.
62. Zhang, H., Chan, D. W., Cancer biomarker discovery in plasma using a tissue-targeted proteomic approach. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1915-1917.
63. Tung, C. L., Lin, S. T., Chou, H. C., Chen, Y. W. et al., Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma. J. Pharm. Biomed. Anal. 2013, 75, 7-17.
64. Sun, G., He, H., Ping, F., Zhang, F., Proteomic diagnosis models from serum for early detection of oral squamous cell carcinoma. Artif. Cells Blood Substit. Immobil. Biotechnol. 2009, 37, 125-129.
65. Zhang, L., Jiang, J., Arellano, M., Yan, X. et al., Quantification of Serum Proteins of Metastatic Oral Cancer Patients Using LC-MS/MS and iTRAQ Labeling. Open Proteomics J. 2008, 1, 72-78.
66. Arellano-Garcia, M. E., Li, R., Liu, X., Xie, Y. et al., Identification of tetranectin as a potential biomarker for metastatic oral cancer. Int. J. Mol. Sci. 2010, 11, 3106-3121.
67. Bijian, K., Mlynarek, A. M., Balys, R. L., Jie, S. et al., Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. J. Proteome Res. 2009, 8, 2173-2185.
68. Wilhelm, M., Schlegl, J., Hahne, H., Moghaddas Gholami, A. et al., Mass-spectrometry-based draft of the human proteome. Nature 2014, 509, 582-587.
69. Kim, M. S., Pinto, S. M., Getnet, D., Nirujogi, R. S. et al., A draft map of the human proteome. Nature 2014, 509, 575-581.